LONDON-- AstraZeneca PLC (AZN.LN) Thursday announced the completion of its agreement to grant the rights to its global anesthetics portfolio outside the U.S. to Aspen Global Incorporated.

Under the previously announced terms of the deal, AGI, a unit of Aspen Pharmacare, will buy commercialization rights outside the U.S. to the portfolio for an upfront payment of $520 million.

The completion announced Thursday does not include Ukraine and Zimbabwe.

-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan

(END) Dow Jones Newswires

September 01, 2016 02:23 ET (06:23 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Astrazeneca Charts.